Masahiro Maeda Selected Research

Formaldehyde (Formol)

8/2007	Napsin A (TA02) is a useful alternative to thyroid transcription factor-1 (TTF-1) for the identification of pulmonary adenocarcinoma cells in pleural effusions.
10/2005	The up-regulation of Y-box binding proteins (DNA binding protein A and Y-box binding protein-1) as prognostic markers of hepatocellular carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masahiro Maeda Research Topics

Disease

33	Neoplasms (Cancer) 10/2023 - 01/2006
16	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 12/2006
16	Mesothelioma 10/2014 - 01/2006
15	Stomach Neoplasms (Stomach Cancer) 12/2021 - 01/2008
6	Amyloid Plaque 01/2023 - 07/2004
6	Lymphoma (Lymphomas) 11/2015 - 10/2011
6	Carcinoma (Carcinomatosis) 05/2015 - 01/2008
5	Cognitive Dysfunction 01/2023 - 06/2011
5	Malignant Mesothelioma 04/2013 - 05/2007
4	Adenocarcinoma 12/2022 - 09/2012
4	Neoplasm Metastasis (Metastasis) 12/2022 - 08/2007
4	Amyloidosis 11/2020 - 10/2014
4	Leukemia 06/2015 - 05/2003
4	Renal Cell Carcinoma (Grawitz Tumor) 04/2011 - 11/2006
3	Pancreatic Neoplasms (Pancreatic Cancer) 12/2022 - 12/2008
3	Lymphatic Metastasis 12/2021 - 01/2012
3	Anemia 01/2021 - 08/2015
3	Arthritis (Polyarthritis) 01/2020 - 04/2004
3	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 10/2005
3	Multiple Myeloma 08/2017 - 10/2003
3	Rheumatoid Arthritis 01/2017 - 02/2009
3	Primary Myelofibrosis (Myelosclerosis) 09/2016 - 11/2013
3	Hemorrhage 06/2015 - 10/2006
2	Ascites 05/2023 - 04/2008
2	Neuroinflammatory Diseases 11/2020 - 01/2017
2	Infections 01/2020 - 11/2013
2	Cataract (Cataracts) 10/2018 - 03/2014
2	Glaucoma 10/2018 - 12/2016
2	Liver Diseases (Liver Disease) 08/2017 - 10/2004
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2017 - 08/2014
2	Renal Insufficiency (Renal Failure) 01/2017 - 04/2011
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 04/2016 - 01/2014
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 06/2015 - 05/2003
2	Essential Thrombocythemia 02/2015 - 01/2014
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 11/2013 - 08/2013
2	Head and Neck Neoplasms (Head and Neck Cancer) 01/2012 - 03/2008
2	Carcinogenesis 04/2011 - 04/2008
2	Osteoarthritis 01/2011 - 02/2009
2	Ovarian Neoplasms (Ovarian Cancer) 08/2010 - 12/2008
2	Pleural Effusion (Pleural Effusions) 08/2007 - 05/2003
2	Lung Neoplasms (Lung Cancer) 11/2005 - 06/2003
2	Pulmonary Tuberculosis 05/2005 - 05/2003
2	Tuberculosis (Tuberculoses) 05/2005 - 05/2003
2	Experimental Arthritis 04/2004 - 02/2004

Drug/Important Bio-Agent (IBA)

21	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2002
19	MesothelinIBA 10/2014 - 09/2006
15	Biomarkers (Surrogate Marker)IBA 08/2017 - 10/2003
12	OsteopontinIBA 04/2011 - 01/2002
11	Amyloid (Amyloid Fibrils)IBA 01/2023 - 04/2003
9	EnzymesIBA 01/2020 - 09/2006
9	ImmunosorbentsIBA 01/2020 - 09/2006
8	Monoclonal AntibodiesIBA 08/2017 - 08/2003
8	AsbestosIBA 10/2014 - 01/2006
7	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 11/2020 - 12/2009
7	Tumor Biomarkers (Tumor Markers)IBA 01/2014 - 09/2006
6	Rituximab (Mabthera)FDA Link 02/2021 - 10/2012
6	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 11/2005
6	Peptides (Polypeptides)IBA 05/2015 - 07/2004
5	AntibodiesIBA 01/2022 - 09/2006
4	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 04/2016
4	Lenalidomide (CC 5013)FDA Link 08/2017 - 12/2013
4	Thrombin FDA Link 01/2011 - 10/2004
3	Prednisolone (Predate)FDA LinkGeneric 01/2017 - 12/2013
3	Docetaxel (Taxotere)FDA Link 01/2017 - 03/2013
3	Phosphotransferases (Kinase)IBA 05/2015 - 03/2007
3	Amyloid beta-PeptidesIBA 12/2006 - 04/2003
2	pembrolizumabIBA 10/2023 - 04/2021
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2023 - 11/2015
2	nephronectinIBA 01/2022 - 01/2020
2	Conditioned Culture MediaIBA 01/2021 - 01/2012
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2020 - 01/2020
2	IntegrinsIBA 01/2020 - 04/2011
2	Presenilin-1IBA 01/2019 - 06/2011
2	Carrier Proteins (Binding Protein)IBA 08/2017 - 10/2005
2	Transforming Growth Factors (Transforming Growth Factor)IBA 08/2015 - 11/2013
2	Azacitidine (5 Azacytidine)FDA Link 08/2015 - 01/2014
2	Imatinib Mesylate (Gleevec)FDA Link 01/2014 - 05/2003
2	DNA-Binding Proteins (DNA Binding Protein)IBA 03/2013 - 10/2005
2	InterferonsIBA 10/2012 - 05/2011
2	Peptide Hydrolases (Proteases)FDA Link 09/2012 - 04/2010
2	Protein Isoforms (Isoforms)IBA 04/2010 - 05/2008
2	Formaldehyde (Formol)FDA Link 08/2007 - 10/2005
2	polyacrylamideIBA 11/2005 - 08/2003
1	Apolipoproteins E (ApoE)IBA 01/2023
1	ApolipoproteinsIBA 01/2023
1	Histones (Histone)IBA 12/2022
1	EstersIBA 12/2022
1	Lysine (L-Lysine)FDA Link 12/2022
1	6-aminonicotinic acidIBA 12/2022
1	Extracellular Matrix ProteinsIBA 01/2022

Therapy/Procedure

28	Therapeutics 10/2023 - 05/2003
13	Drug Therapy (Chemotherapy) 12/2021 - 05/2003
6	Gastrectomy 10/2023 - 08/2017
2	Pancreatectomy 10/2023 - 03/2013
2	Lymph Node Excision (Lymph Node Dissection) 12/2021 - 02/2021
2	Trabeculectomy (Trabeculoplasty) 10/2018 - 12/2016
2	Immunotherapy 01/2017 - 12/2008
2	Plasma Exchange 01/2017 - 08/2014
2	Combined Modality Therapy 10/2014 - 04/2014
1	Splenectomy 10/2023